Liphetho tse potlakileng ka mor'a metsotso e 15-30 Rapid antigen kit AMRDT120

Teko e potlakileng bakeng sa ho lemoha boleng ba ho se nke lehlakore

Li-antibodies ho SARS-CoV-2 kapa liente tsa eona maling a felletseng, serum kapa plasma.

Tlhaloso ea Pakete: 40 T/kit, 20 T/kit, 10 T/kit, 1 T/kit.

Boikutlo bo Lekanyelitsoeng: 96.97% (95% CI: 83.35% ~ 99.99%)
Tsebo e Itseng: 100.00% (95%CI:97.29% ~100.00%)
Ho nepahala: 99.50% (95% CI: 96.94% ~ 99.99%)

Mekotla ea foil, e nang le li-cassette tsa tlhahlobo le li-desiccants *20
Assay buffer *20 linkho;
Li-droppers tse lahliloeng * 20;
Lancet *20
Lodine swab*20
Litaelo tsa tšebeliso*1

Liphetho tse potlakileng ka mor'a metsotso e 15-30 Rapid antigen kit AMRDT120 TŠEBELETSO E REETSOENG
Tlhahlobo e potlakileng ea SARS-CoV-2 Neutralizing Antibody Rapid (COVID-19 Ab) ke tlhahlobo e potlakileng ea chromatographic immunoassay bakeng sa tlhahlobo ea boleng ba li-antibodies ho SARS-CoV-2 maling a felletseng, serum kapa plasma.

Liphetho tse potlakileng ka mor'a metsotso e 15-30 Rapid antigen kit AMRDT120 PRINCIPLE
Tlhahlobo e potlakileng ea SARS-CoV-2 Neutralizing Antibody Rapid (COVID-19 Ab) ke ea ho lemoha li-antibodies ho SARS-CoV-2 kapa liente tsa eona.Cell surface receptor angiotensin converting enzyme-2 (ACE2) e koahetsoe sebakeng sa liteko le sebaka sa recombinant receptor-binding domain (RBD) se kopantsoeng le likaroloana tse bontšang.

Nakong ea tlhahlobo, haeba ho na le li-antibodies tsa SARS-CoV-2 tse sa sebetseng ka har'a mohlala, e ne e tla sebetsana le protheine ea RBD-particle conjugate mme e se ke ea sebetsana le protheine e koahetsoeng esale pele ea ACE2.Motsoako o ntan'o fallela holimo ho lera la chromatographically ka ts'ebetso ea capillary 'me o ne o ke ke oa tšoaroa ke antigen e koahetsoeng pele.Tlhahlobo e potlakileng ea SARS-CoV-2 Neutralizing Antibody Rapid (COVID-19 Ab) e na le likaroloana tse koahetsoeng ke protheine RBD.Protheine ea ACE2 e koahetsoe sebakeng sa liteko.